Latest Insider Transactions at Akouos, Inc. (AKUS)
This section provides a real-time view of insider transactions for Akouos, Inc. (AKUS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Akouos, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Akouos, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 30
2022
|
New Enterprise Associates 16, L.P. > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
4,294,207
-100.0%
|
-
|
|
Nov 30
2022
|
Forest Baskett > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
4,294,207
-100.0%
|
-
|
|
Nov 30
2022
|
Ali Behbahani > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
4,294,207
-100.0%
|
-
|
|
Nov 30
2022
|
Carmen Chang > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
4,294,207
-100.0%
|
-
|
|
Nov 30
2022
|
Anthony A. Florence Jr. > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
4,294,207
-100.0%
|
-
|
|
Nov 30
2022
|
Mohamad Makhzoumi > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
4,294,207
-100.0%
|
-
|
|
Nov 30
2022
|
Scott D Sandell > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
4,294,207
-100.0%
|
-
|
|
Nov 30
2022
|
Peter W. Sonsini > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
4,294,207
-100.0%
|
-
|
|
Nov 30
2022
|
Paul Edward Walker > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
4,294,207
-100.0%
|
-
|
|
Nov 30
2022
|
Michael John Mc Kenna Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
82,385
-100.0%
|
-
|
|
Nov 30
2022
|
Kush Parmar Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
4,135,786
-100.0%
|
-
|
|
Nov 30
2022
|
Heather Preston Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,882
-100.0%
|
-
|
|
Nov 30
2022
|
Emmanuel Simons Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
272,582
-100.0%
|
-
|
|
Nov 30
2022
|
Arthur Tzianabos Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
26,930
-100.0%
|
-
|
|
Nov 30
2022
|
Jennifer Anne Wellman CHIEF OPERATING OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
12,338
-100.0%
|
-
|
|
Nov 30
2022
|
5 Am Ventures V, L.P. > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
4,135,786
-100.0%
|
-
|
|
Nov 30
2022
|
Kearny Acquisition Corp > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
29,992,668
+100.0%
|
$359,912,016
$12.5 P/Share
|
|
Dec 29
2020
|
5 Am Ventures V, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
470,000
-10.2%
|
$8,460,000
$18.0 P/Share
|
|
Dec 29
2020
|
Kush Parmar Director |
SELL
Open market or private sale
|
Indirect |
470,000
-10.2%
|
$8,460,000
$18.0 P/Share
|
|
Jun 30
2020
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,176,000
+37.31%
|
$19,992,000
$17.0 P/Share
|
|
Jun 30
2020
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
799,984
+50.0%
|
-
|
|
Jun 30
2020
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
825,000
+26.56%
|
$14,025,000
$17.0 P/Share
|
|
Jun 30
2020
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,456,249
+39.59%
|
-
|
|
Jun 30
2020
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
290,000
+26.85%
|
$4,930,000
$17.0 P/Share
|
|
Jun 30
2020
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
499,989
+50.0%
|
-
|
|
Jun 30
2020
|
Novartis Bioventures LTD |
BUY
Open market or private purchase
|
Indirect |
125,000
+9.57%
|
$2,125,000
$17.0 P/Share
|
|
Jun 30
2020
|
Novartis Bioventures LTD |
BUY
Conversion of derivative security
|
Indirect |
1,056,258
+32.96%
|
-
|